Home|Journals|Articles by Year|Audio Abstracts
 

Original Article

Ann Med Res. 2015; 22(3): 176-179


Our Experience with Narrow-Band UVB for 15 Years: A Retrospective Study of 205 Patients

Okan Kizilyel, Omer Faruk Elmas, Mahmut Sami Metin, Akin Aktas.




Abstract
Cited by 0 Articles

Aim: Widely used in many indications in dermatology practice, narrow-band ultraviolet B is a kind of ultraviolet with a wavelength usually condensing at 312nm. Our aim in this study is to introduce our 15-year experience with narrow-band UVB on 205 patients.
Materials and Methods: Gender, diagnosis, distribution of lesions, beginning dose, maximum dose, number of sessions, and cumulative dose of patients treated with narrow band UVB were retrospectively studied.
Results: The mean age of patients was 37,2 years. 44,4% of the patients was males, 55,6% was females. 34,1% of the patients were diagnosed with psoriasis and 14,6% of the patients with mycosis fungoides. 73,7% of distribution of lesions was diffused, 28% was central, and 26% was peripheral. The mean number of sessions was 27,1 and the mean cumulative dose was 21070 mJ/cm2 in the first treatment. The mean starting dose was 125,4 mJ/cm2 and the mean maximum dose was 21070 mJ/cm2.
Conclusion: Differences between the means of the number of sessions, maximum doses, cumulative doses, and diseases were statistically significant.

Key words: Mycosis Fungoides; Narrow Band UVB; Phototherapy; Psoriasis.






Full-text options


Share this Article


Online Article Submission
• ejmanager.com




ejPort - eJManager.com
Refer & Earn
JournalList
About BiblioMed
License Information
Terms & Conditions
Privacy Policy
Contact Us

The articles in Bibliomed are open access articles licensed under Creative Commons Attribution 4.0 International License (CC BY), which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.